tensinomab

N/A

Report date: 2025/03/20 10:04:17

Base Information

Drug Nametensinomab
Drug Alias NamescFv mAb (OncoBioPharm)single-chain variable fragment monoclonal antibody (OncoBioPharm)single-chain variable fragment mAb (OncoBioPharm)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesOncoBioPharm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOncoBioPharm Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A